Aurelio Perez-Favila

Aurelio Perez-Favila

Auto-generated profile, based on publicly available information

Aurelio Perez-Favila

Univ Autonoma Zacatecas, Mol Med Lab, Unidad Acad Med Humana & CS, Zacatecas, Mexico

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Margarita L. Martinez-FierroMargarita L. Martinez-Fierro
Margarita L. Martinez-Fierro
APAurelio Perez-Favila
Aurelio Perez-Favila
Sideré Monserrath Zorrilla AlfaroSideré Monserrath Zorrilla Alfaro
Sideré Monserrath Zorrilla Alfaro
SLSergio A. Oropeza-De Lara
Sergio A. Oropeza-De Lara
IGIdalia Garza-Veloz
Idalia Garza-Veloz
IRIram Pablo Rodriguez-Sanchez
Iram Pablo Rodriguez-Sanchez
Objectives: To analyze the gene variants of the renin-angiotensin-aldosterone system and determine their association with the severity and outcome of COVID-19. Methods: A total of 104 patients were included in the study: 34 asymptomatic patients with COVID-19 as controls and 70 symptomatic patients as cases. The genetic variants ACE rs4343, ACE2 rs2074192, AGTR1 rs5182, and AGT rs4762 were identified using TaqMan genotyping tests. Results: Patients with the T/T genotype of AGTR1 rs5182 have a higher probability of developing symptomatic COVID-19 (odds ratio [OR] 12.25, 95% confidence interval [CI] 1.34-111.9, P <= 0.001) and a higher risk of hospitalization because of disease (OR 14.00, 95% CI 1.53-128.49, P = 0.012). The haplotype CTG ( AGTR1 rs5182, ACE2 rs2074192, ACE rs4343) decreased the odds of death related to COVID-19 in the study population (OR 0.03, 95% CI 0.0-0.06, P = 0.026). Conclusions: The T/T genotype of the AGTR1 rs5182 variant increased the probability of symptomatic COVID-19 and hospitalization, whereas the haplotype CTG (consisting of AGTR1 rs5182, ACE2 rs2074192, and ACE rs4343) decreased the odds of death related to COVID-19 by 97% in the hospitalized patients with COVID-19. These results support the participation of renin-angiotensin-aldosterone system gene variants as modifiers of the severity of symptoms associated with SARS-CoV-2 infection and the outcome of COVID-19. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )